Marita L. Mariotti
Meldola, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer.
Journal: JAMA network open
Published: July 14, 2026
Artificial intelligence for predicting pathological complete response to neoadjuvant therapy in triple-negative breast cancer: A systematic review and meta-analysis.
Journal: Breast (Edinburgh, Scotland)
Published: April 24, 2026
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future Directions.
Journal: Cancers
Published: September 01, 2025
Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives.
Journal: Clinical & experimental metastasis
Published: July 09, 2024
CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial.
Journal: The oncologist
Published: September 14, 2023
A New Potential Resource in the Fight against Candida auris: the Cinnamomum zeylanicum Essential Oil in Synergy with Antifungal Drug.
Journal: Microbiology spectrum
Published: March 28, 2023
Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer.
Journal: Cancers
Published: November 30, 2022
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology.
Journal: Frontiers in oncology
Published: October 28, 2022
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer.
Journal: International journal of molecular sciences
Published: September 29, 2022
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations.
Journal: Translational oncology
Published: February 18, 2022
Last Updated: 09/26/2026